Dmitry Balyasny’s Edwards Lifesciences EW Stock Holding History

Dmitry Balyasny’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-34,500	Closed	-$2.94M	–	3067
2025 Q4	$2.94M	Sell	34,500 -17,700	-34%	-$1.45M	﹤0.01%	1677
2025 Q3	$4.06M	Buy	52,200 +36,100	+224%	+$2.82M	0.01%	1464
2025 Q2	$1.26M	Sell	16,100 -6,200	-28%	-$462K	﹤0.01%	1957
2025 Q1	$1.62M	Buy	+22,300	New	+$1.6M	﹤0.01%	1805
2024 Q4	–	Sell	-12,100	Closed	-$798K	–	2890
2024 Q3	$798K	Buy	+12,100	New	+$879K	﹤0.01%	2052
2024 Q2	–	Sell	-24,700	Closed	-$2.36M	–	2716
2024 Q1	$2.36M	Buy	+24,700	New	+$2.07M	﹤0.01%	1490
2021 Q3	–	Sell	-8,000	Closed	-$829K	–	2081
2021 Q2	$829K	Buy	+8,000	New	+$754K	﹤0.01%	1373
2019 Q2	–	Sell	-120,000	Closed	-$7.65M	–	1546
2019 Q1	$7.65M	Buy	+120,000	New	+$6.85M	0.05%	462

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Dmitry Balyasny's EW Position: Q2 2026 in Review

Dmitry Balyasny increased its Edwards Lifesciences (EW) stake by 4,463% in Q2 2026, buying an estimated $37.4M and bringing the position to 456,202 shares worth $41.3M. The position accounts for 0.05% of the portfolio, ranked #425.

Dmitry Balyasny first reported a position in EW in Q2 2013 and has held it in 34 quarters since. The position peaked at $154M in Q1 2025. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Dmitry Balyasny held 456,202 shares of Edwards Lifesciences worth $41.3M as of Q2 2026.
Dmitry Balyasny bought 446,204 Edwards Lifesciences shares in Q2 2026, an estimated $37.4M.
Edwards Lifesciences made up 0.05% of Dmitry Balyasny's portfolio in Q2 2026, its #425 holding.
Dmitry Balyasny first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 34 quarters since.
Dmitry Balyasny's Edwards Lifesciences position peaked at $154M in Q1 2025.
1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.